RS50210B - Derivati (1-fenaci-3-fenil-3-piperidiletil) piperidina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže - Google Patents

Derivati (1-fenaci-3-fenil-3-piperidiletil) piperidina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže

Info

Publication number
RS50210B
RS50210B YUP-564/01A YUP56401A RS50210B RS 50210 B RS50210 B RS 50210B YU P56401 A YUP56401 A YU P56401A RS 50210 B RS50210 B RS 50210B
Authority
RS
Serbia
Prior art keywords
alkyl
atom
phenyl
phenacy
piperidylethyl
Prior art date
Application number
YUP-564/01A
Other languages
English (en)
Inventor
Jean Philippe Ducoux
Xavier Emonds-Alt
Patrick Gueule
Vincenzo Proietto
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9901593A external-priority patent/FR2789389B3/fr
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of YU56401A publication Critical patent/YU56401A/sh
Publication of RS50210B publication Critical patent/RS50210B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Jedinjenjc formule:gde -Ar predstavlja jedan fcnil monosupstituisan ili dvostruko supstituisan jednim atomom halogcna, ili (C1-C3)alkilom, -X predstavlja jednu grupu -R1 predstavlja jedan atom hlora, atom broma, (C1-C3) alkil ili trifluorometil, -R2 predstavlja jednu grupu -CR3R4CONR5R6, -R3 i R4 predstavljaju isti radikal biran od metila, etila n-propila ili n-butila, -ili, alternativno, R3 i R4, zajedno sa ugljenikovim atomom na koji su vezani sačinjavaju jedan (C3-C6) cikloalkil, -R5 i R6 svaki nezavisno predstavljaju vodonik ili (C1C3) alkil, -ili, alternativno, R5 i R6, zajedno sa atomom azota na koji su vezani, obrazuju jedan heterocikličan radikal biran od 1-azetidinila, 1-pirolidinila, 1-piperidila, 4-morfolinila, 4-tiomorfolinila ili perhidro-l-azepinila.kao i njegove moguće soli sa neorganskim ili organskim kiselinama i njihovim solvatima i/ili hidratima.Prijava sadrži još 26 patentnih zahteva
YUP-564/01A 1999-02-10 2000-02-08 Derivati (1-fenaci-3-fenil-3-piperidiletil) piperidina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže RS50210B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9901593A FR2789389B3 (fr) 1999-02-10 1999-02-10 Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
FR9904429A FR2789390B3 (fr) 1999-02-10 1999-04-07 Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
YU56401A YU56401A (sh) 2004-03-12
RS50210B true RS50210B (sr) 2009-07-15

Family

ID=26234812

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-564/01A RS50210B (sr) 1999-02-10 2000-02-08 Derivati (1-fenaci-3-fenil-3-piperidiletil) piperidina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže

Country Status (37)

Country Link
US (2) US6642233B1 (sr)
EP (1) EP1150970B1 (sr)
JP (1) JP4648544B2 (sr)
KR (1) KR100611261B1 (sr)
CN (1) CN1273463C (sr)
AR (1) AR028813A1 (sr)
AT (1) ATE370942T1 (sr)
AU (1) AU763716B2 (sr)
BG (1) BG65031B1 (sr)
BR (1) BR0008067A (sr)
CA (1) CA2360894C (sr)
CO (1) CO4980896A1 (sr)
CZ (1) CZ300765B6 (sr)
DE (1) DE60036081T2 (sr)
DK (1) DK1150970T3 (sr)
EE (1) EE04437B1 (sr)
ES (1) ES2291187T3 (sr)
FR (1) FR2789390B3 (sr)
HK (1) HK1038927A1 (sr)
HR (1) HRP20010566A2 (sr)
HU (1) HUP0201281A3 (sr)
ID (1) ID29219A (sr)
IL (2) IL144363A0 (sr)
ME (1) MEP11908A (sr)
NO (2) NO321149B1 (sr)
NZ (1) NZ513053A (sr)
PE (1) PE20001463A1 (sr)
PL (1) PL198561B1 (sr)
PT (1) PT1150970E (sr)
RS (1) RS50210B (sr)
RU (1) RU2220956C2 (sr)
SI (1) SI1150970T1 (sr)
SK (1) SK286401B6 (sr)
TR (1) TR200102331T2 (sr)
TW (1) TWI254712B (sr)
UA (1) UA70986C2 (sr)
WO (1) WO2000047572A1 (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003217535A1 (en) * 2002-02-20 2003-09-09 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids
US20050009798A1 (en) * 2002-02-20 2005-01-13 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
MXPA06008648A (es) * 2004-01-30 2006-09-04 Pfizer Prod Inc Composiciones farmaceuticas de antagonistas del receptor de neuroquinina y ciclodextrina y metodos para una tolerancia mejorada en el sitio de inyeccion.
FR2873373B1 (fr) * 2004-07-23 2006-09-08 Sanofi Synthelabo Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
GB2452696B (en) * 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
DE102008015425A1 (de) * 2008-03-20 2010-01-21 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen zur Verringerung von Juckreiz und anderen dermatologischen Missempfindungen, die insbesondere bei Altershaut auftreten können, mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid
DE102008015428A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende Zubereitungen für den humanen Haut- und/oder Schleimhautkontakt mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid
DE102008015426A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US512901A (en) * 1894-01-16 Folding bed
GB821012A (en) * 1957-01-15 1959-09-30 Rhone Poulenc Sa New phenthiazine derivatives and processes for their preparation
FR2676055B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
CN1067385C (zh) 1994-08-25 2001-06-20 默里尔药物公司 用于治疗变应性疾病的新的取代的哌啶类化合物
CA2162786A1 (en) * 1994-11-22 1996-05-23 Philip Arthur Hipskind Heterocyclic tachykinin receptor antagonists

Also Published As

Publication number Publication date
IL180579A0 (en) 2007-06-03
SK286401B6 (sk) 2008-09-05
CN1345317A (zh) 2002-04-17
HRP20010566A2 (en) 2002-08-31
US6642233B1 (en) 2003-11-04
US20040072840A1 (en) 2004-04-15
NO20013878L (no) 2001-10-10
NO20013878D0 (no) 2001-08-08
JP2002536442A (ja) 2002-10-29
HUP0201281A2 (en) 2002-09-28
CO4980896A1 (es) 2000-11-27
CA2360894A1 (en) 2000-08-17
SI1150970T1 (sl) 2008-02-29
ID29219A (id) 2001-08-16
YU56401A (sh) 2004-03-12
US6951940B2 (en) 2005-10-04
EE200100417A (et) 2002-12-16
EP1150970B1 (fr) 2007-08-22
ES2291187T3 (es) 2008-03-01
KR100611261B1 (ko) 2006-08-10
RU2220956C2 (ru) 2004-01-10
KR20010101818A (ko) 2001-11-14
DE60036081T2 (de) 2008-05-15
MEP11908A (en) 2010-06-10
HK1038927A1 (en) 2002-04-04
DE60036081D1 (de) 2007-10-04
IL144363A0 (en) 2002-05-23
FR2789390B3 (fr) 2001-03-09
NO20051958L (no) 2001-10-10
BG105794A (en) 2002-05-31
HUP0201281A3 (en) 2003-05-28
ATE370942T1 (de) 2007-09-15
SK11392001A3 (sk) 2002-02-05
FR2789390A1 (fr) 2000-08-11
PT1150970E (pt) 2007-11-07
BG65031B1 (bg) 2006-12-29
AU763716B2 (en) 2003-07-31
CZ20012888A3 (cs) 2001-11-14
EP1150970A1 (fr) 2001-11-07
JP4648544B2 (ja) 2011-03-09
PL198561B1 (pl) 2008-06-30
WO2000047572A1 (fr) 2000-08-17
TR200102331T2 (tr) 2002-03-21
TWI254712B (en) 2006-05-11
PL350243A1 (en) 2002-12-02
NO321149B1 (no) 2006-03-27
CN1273463C (zh) 2006-09-06
CA2360894C (en) 2009-09-22
AU2553100A (en) 2000-08-29
UA70986C2 (uk) 2004-11-15
EE04437B1 (et) 2005-02-15
PE20001463A1 (es) 2001-02-21
CZ300765B6 (cs) 2009-08-05
DK1150970T3 (da) 2007-12-17
AR028813A1 (es) 2003-05-28
BR0008067A (pt) 2001-11-06
NZ513053A (en) 2002-10-25

Similar Documents

Publication Publication Date Title
MEP22008A (en) Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
SU1470183A3 (ru) Способ получени амидных производных хинолина или их солей присоединени кислоты
MEP12608A (en) Derivatives of n-[phenyl (pyrrolidine-2-yl) methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
HRP20070529T3 (en) Imidazole derivatives as glutmate receptor antagonists
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
MXPA03011638A (es) Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
AR048642A1 (es) Compuestos de metil-aril o heteroaril-amida sustituida utiles como antagonistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento
NO20060219L (no) Forbindelser
MEP25608A (en) Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
HRP20050213A2 (en) 2,4-substituted indoles and their use as 5-ht6 modulators
TW200510441A (en) Novel compounds
CO5011090A1 (es) Derivados de acil-piperazinil-pirimidinas, procedimiento para su preparacion y composiciones farmaceuticas de los mismos
HRP20050390A2 (en) Substituted benzoxazinones and uses thereof
HRP20040429B1 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
NO20072409L (no) Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
NO970349L (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT inhibitorer
CO5720994A2 (es) Derivados sustituidos del pirrol
AR041246A1 (es) Derivados de piridina; un procedimiento de preparacion de los mismos y composicion farmaceutica que los contiene
DE69925472D1 (de) Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
CO5550439A2 (es) Compuestos derivados de arilsulfonil-piperazina que tienen afinidad al receptor 5-ht6 y composiciones farmaceuticas que los contienen
RS50210B (sr) Derivati (1-fenaci-3-fenil-3-piperidiletil) piperidina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
CO4940505A1 (es) Antagonistas de receptor de benzoxazinona dopamina d 4
CO5660263A2 (es) Derivados de imidazol heteroaril sustituidos como antagonistas del receptor de glutamato
HRP20080363T3 (en) Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists